Shortage of home COVID-19 tests hurts fight against pandemic, experts say
CBSN
The U.S. has a surplus of coronavirus vaccines. What it lacks, unlike countries in Asia and Europe, is an adequate supply of rapid COVID-19 tests that Americans can administer in the comfort of their own home.
Try to get your hands on a pack of over-the-counter COVID-19 tests at your local pharmacy and you're likely to find empty shelves. If any are in stock, they will cost roughly $24 a pair — a hefty price for many Americans. That helps explain why it is the norm for consumers to check their health status only when traveling or attending a special event, rather than using a rapid antigen test regularly, which experts say is a more effective way to contain the disease.
To alleviate the problem, the Biden administration this month announced it would invest $1 billion to expand the supply of at-home COVID-19 tests. President Joe Biden in September invoked the Defense Production Act to increase the production of rapid testing kits and help major retailers make them more accessible. He also pledged $2 billion to make roughly 280 million tests, although that amounts to less than one test a year per U.S. resident.

NASA announced ambitious long-range plans Tuesday to spend $20 billion over the next seven years to build a moon base near the lunar south pole featuring habitats, pressurized rovers and nuclear power systems. The announcement came just over a week before the planned launch of NASA's Artemis II around-the-moon mission. In:

The Trump administration deployed ICE and other Homeland Security agents to 14 of the nation's airports on Monday to help shuttle passengers through overcrowded TSA checkpoints. In one airport, the security line wait-time was up to six hours. Nicole Sganga and Kaia Hubbard contributed to this report. In:











